Essebag, Vidal <br/><br/>
Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial.  [electronic resource] 

 -  Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology  Oct 2017 
 - 1630-1636 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1532-2092 
<br/><br/><label>Standard No.: </label>10.1093/europace/euw409  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Anticoagulants--administration & dosage<br/>Antithrombins--administration & dosage<br/>Atrial Fibrillation--complications<br/>Dabigatran--administration & dosage<br/>Defibrillators, Implantable<br/>Drug Administration Schedule<br/>Drug Substitution<br/>Female<br/>Hematoma--chemically induced<br/>Hemorrhage--chemically induced<br/>Heparin--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Pacemaker, Artificial<br/>Prosthesis Implantation--adverse effects<br/>Thrombosis--etiology<br/>Time Factors<br/>Treatment Outcome<br/>Warfarin--administration & dosage